申请人:Respivert Ltd.
公开号:US20180118754A1
公开(公告)日:2018-05-03
The present invention relates to compounds of formula (I)
and to compositions comprising the same and to the use of the compounds and their compositions in treatment, for example in the treatment of inflammatory diseases, in particular respiratory inflammatory disease. The invention also extends to methods of making said compounds.